BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26985336)

  • 1. Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.
    Zahiri Z; Sharami SH; Milani F; Mohammadi F; Kazemnejad E; Ebrahimi H; Dalil Heirati SF
    Int J Fertil Steril; 2016; 9(4):490-6. PubMed ID: 26985336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
    Pourteymour Fard Tabrizi F; Alipoor B; Mehrzad Sadaghiani M; Ostadrahimi A; Malek Mahdavi A
    Int J Fertil Steril; 2013 Jan; 6(4):244-9. PubMed ID: 24520447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of metabolic syndrome in four phenotypes of PCOS and its relationship with androgenic components among Iranian women: A cross-sectional study.
    Zaeemzadeh N; Sadatmahalleh SJ; Ziaei S; Kazemnejad A; Mottaghi A; Mohamadzadeh N; Movahedinejad M
    Int J Reprod Biomed; 2020 Apr; 18(4):253-264. PubMed ID: 32494764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic compromise in women with PCOS: earlier than expected.
    Lana MP; Demayo S; Giannone L; Nolting M; D'isa E; Servetti V; Rolo G; Gutierrez G; Jarlip M
    Rev Assoc Med Bras (1992); 2020 Sep; 66(9):1225-1228. PubMed ID: 33027449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prevalence of metabolic syndrome and insulin resistance according to the phenotypic subgroups of polycystic ovary syndrome in a representative sample of Iranian females.
    Mehrabian F; Khani B; Kelishadi R; Kermani N
    J Res Med Sci; 2011 Jun; 16(6):763-9. PubMed ID: 22091305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of sex hormone-binding globulin on predicting metabolic syndrome in newly diagnosed and untreated patients with polycystic ovary syndrome.
    Fu C; Minjie C; Weichun Z; Huihuang Y; Guishan C; Qingxia H; Xiaoping Y; Lan C; Ping W; Chujia L; Guoshu Y
    Hormones (Athens); 2020 Sep; 19(3):439-445. PubMed ID: 32562143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
    Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
    Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis.
    Niksima SH; Odel NM; Khaki S; Ghanei Gheshlagh R; Fallahi A; Kurdi A
    Diabetes Metab Syndr; 2019; 13(3):1911-1915. PubMed ID: 31235114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of metabolic syndrome in women with polycystic ovary syndrome.
    Ersan F; Arslan E; Esmer AÇ; Aydın S; Gedikbaşı A; Gedikbaşı A; Alkış I; Ark C
    J Turk Ger Gynecol Assoc; 2012; 13(3):178-83. PubMed ID: 24592034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis.
    Hallajzadeh J; Khoramdad M; Karamzad N; Almasi-Hashiani A; Janati A; Ayubi E; Pakzad R; Sullman MJM; Safiri S
    J Cardiovasc Thorac Res; 2018; 10(2):56-69. PubMed ID: 30116503
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study.
    Kyrkou G; Trakakis E; Attilakos A; Panagopoulos P; Chrelias C; Papadimitriou A; Vaggopoulos V; Alexiou E; Mastorakos G; Lykeridou A; Kassanos D; Papaevangelou V; Papantoniou N
    Arch Gynecol Obstet; 2016 Apr; 293(4):915-23. PubMed ID: 26615602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome in young women with the polycystic ovary syndrome: revisiting the threshold for an abnormally decreased high-density lipoprotein cholesterol serum level.
    Dewailly D; Contestin M; Gallo C; Catteau-Jonard S
    BJOG; 2010 Jan; 117(2):175-80. PubMed ID: 19832825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome.
    Glueck CJ; Papanna R; Wang P; Goldenberg N; Sieve-Smith L
    Metabolism; 2003 Jul; 52(7):908-15. PubMed ID: 12870169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
    Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
    J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women.
    Boyle JA; Cunningham J; Norman RJ; Dunbar T; O'Dea K
    Intern Med J; 2015 Dec; 45(12):1247-54. PubMed ID: 26387977
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.